| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 703442 | Null | 0.0385613993886 | 0.12204109 |
| NSC 750104 | 5,10-dimethoxybenzo[g]quinolin-2(1H)-one | 0.0385613993886 | -0.07495434 |
| NSC 759016 | Null | 0.0385613993886 | 0.36532752 |
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0385613993886001 | 0.25397951 |
| NSC 126228 | Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0385613993886001 | 0.30202467 |
| NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.0385613993886001 | 0.46603291 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0385613993886001 | 0.37901604 |
| NSC 185065 | Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- | 0.0385613993886001 | 0.20591817 |
| NSC 18805 | .gamma.-Thujaplicine | 0.0385613993886001 | 0.4883603 |
| NSC 30722 | Pyrimidine, 2,4,6-trichloro-5-methyl- | 0.0385613993886001 | 0.27063733 |